1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
665E35237F4A1AF4800258B3B0031BF25
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-commercial-collaboration-growth-areas-success-stories-field-interactions?opendocument
18
19opendocument
2044.201.97.138
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Affairs Excellence

Medical-Commercial Collaboration and Growth Areas: Success Stories and Field Interactions

ID: 5809


Features:

14 Info Graphics

4 Data Graphics

40+ Metrics

9 Narratives


Pages/Slides: 24


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Medical-Commercial Collaboration and Growth Areas: Success Stories and Field Interactions”

STUDY OVERVIEW

In the dynamic biopharma industry, the seamless integration of Medical Affairs and Commercial functions is crucial for driving transformative advancements. Effective collaboration between these groups not only streamlines operations but also fosters innovation and accelerates the delivery of therapeutic solutions to the market.

Best Practices, LLC’s benchmarking research delves into successful collaboration models, providing Medical Affairs leaders with a detailed understanding of effective integration strategies. This includes identifying key collaboration partners, establishing effective field interaction policies, and showcasing notable success stories that underscore the benefits of a cohesive approach. The insights garnered from this research are essential for leaders who aim to replicate these successful models and enhance their own collaborative efforts.


KEY TOPICS

  • Collaboration Modes and Leadership in Partnerships
  • Success Stories in Launch Strategies, Education, Training, Digital Systems, and KOL Engagement
  • Key Commercial and Medical Partners
  • Top Collaboration Models
  • Field Interaction Policies

KEY METRICS

  • Collaboration levels between Medical Affairs and Commercial teams
  • Primary collaboration modes between Medical and Commercial teams
  • Key drivers fostering collaboration between Medical Affairs and Commercial teams
  • Recent programs/pilots with successful Medical-Commercial collaboration
  • Frequency of collaboration between Medical Affairs and primary Commercial partners
  • Key Medical collaborators interacting frequently with Commercial colleagues
  • Top-ranked collaboration approaches

SAMPLE KEY FINDINGS

  • Top Modes of Collaboration: Medical most often engages with Commercial counterparts via synched Medical-Brand strategies (83%), shared engagement plans for large (68%) and individual (30%) customers, cross-functional training (55%), and shared digital systems (43%).

METHODOLOGY

This study is powered by insights from 40 Medical Affairs leaders collaborating with Commercial at 33 global biopharma organizations. Functions represented in this study include: C-suite, Medical Strategy, Medical Operations, Field Medical, Medical Education, Medical Information, and Medical Excellence. Best Practices LLC also conducted deep-dive interviews with Medical Affairs leaders to capture additional insights.

Industries Profiled:
Biotech; Pharmaceutical; Biopharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical; Clinical Research; Laboratories


Companies Profiled:
Allergan; Asklepion Pharmaceuticals; LLC; AstraZeneca; Axsome Therapeutics; Bayer; bioMerieux; CSL Behring; embecta; Fresenius; Genentech; Gilead Sciences; Grünenthal; Jazz Pharmaceuticals; Kyowa Kirin; Merck; Merck KGaA; Merz Pharma; Micromed; Novartis; OM Pharma; Partner Therapeutics (PTx); Pfizer; Pixacore; Radius Health; Inc.; Sandoz; Sanofi; Santen; Servier; Sobi; Supernus; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.